Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 12,895 | 1,395 | 0 | 0 | 0 |
| Cost of Goods | 512 | N/A | N/A | N/A | N/A |
| Gross Profit | 12,383 | 1,395 | N/A | N/A | N/A |
| Operating Expenses | 141,056 | 116,973 | 99,687 | 44,372 | 26,814 |
| Operating Income | -128,161 | -115,578 | -99,687 | -44,372 | -26,814 |
| Interest Expense | 1,037 | 0 | 0 | 0 | 0 |
| Other Income | 2,241 | 146 | 583 | 1,087 | 149 |
| Pre-tax Income | -126,957 | -115,432 | -99,104 | -43,285 | -26,665 |
| Income Tax | -13,392 | -1,000 | -523 | 0 | -187 |
| Net Income Continuous | -113,565 | -114,432 | -98,581 | -43,285 | -26,478 |
| Net Income | $-113,565 | $-114,432 | $-98,581 | $-43,285 | $-26,478 |
| EPS Basic Total Ops | -1.52 | -1.81 | -1.88 | -1.06 | -1.19 |
| EPS Basic Continuous Ops | -1.52 | -1.81 | -1.88 | -1.06 | -1.18 |
| EPS Diluted Total Ops | -1.52 | -1.81 | -1.88 | -1.06 | -1.19 |
| EPS Diluted Continuous Ops | -1.52 | -1.81 | -1.88 | -1.06 | -1.18 |
| EPS Diluted Before Non-Recurring Items | -1.52 | -1.81 | -1.88 | -1.06 | -1.19 |
| EBITDA(a) | $-126,896 | $-114,653 | $-99,407 | $-44,388 | $-26,814 |